Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farb

Showing results (71-80 of 553) with videos related to

Pageof 56
Sort By:
Nucleic Acids Research|January 22, 1982
Distribution of the core histones H2A.H2B.H3 and H4 during cell replicationE Fowler, R Farb, S El-Saidy
Cardiology Clinics|February 1, 1992
Anatomy and pathology of the right ventricle (including acquired tricuspid and pulmonic valve disease)A Farb, A P Burke, R Virmani
Molecular Pharmacology|December 1, 1988
"Run-down" of gamma-aminobutyric acidA receptor function during whole-cell recording: a possible role for phosphorylationM Gyenes, M Farrant, D H Farb
Human Pathology|June 1, 1995
Pathobiological determinants of cocaine-associated cardiovascular syndromesF D Kolodgie, A Farb, R Virmani
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|October 24, 2001
Sudden cardiac deathR Virmani, A P Burke, A Farb
Human Pathology|July 1, 1993
Ischemia from myocardial coronary bridging: fact or fancy?R Virmani, A Farb, A P Burke
American Heart Journal|January 1, 1994
Coronary angioplasty from the perspective of atherosclerotic plaque: morphologic predictors of immediate success and restenosisR Virmani, A Farb, A P Burke
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 1, 1991
The pathology of primary pulmonary hypertensionA P Burke, A Farb, R Virmani
Journal of the American College of Cardiology|July 1, 1991
Limitation of no reflow injury by blood-free reperfusion with oxygenated perfluorochemical (Fluosol-DA 20%)F D Kolodgie, R Virmani, A Farb
The American Heart Hospital Journal|December 18, 2004
Drug-eluting stents: are they really safe?Renu Virmani, Frank D Kolodgie, Andrew Farb
Pageof 56

Showing results (71-80 of 553) with videos related to

Sort By:
Pageof 56
Nucleic Acids Research|January 22, 1982
Distribution of the core histones H2A.H2B.H3 and H4 during cell replicationE Fowler, R Farb, S El-Saidy
Cardiology Clinics|February 1, 1992
Anatomy and pathology of the right ventricle (including acquired tricuspid and pulmonic valve disease)A Farb, A P Burke, R Virmani
Molecular Pharmacology|December 1, 1988
"Run-down" of gamma-aminobutyric acidA receptor function during whole-cell recording: a possible role for phosphorylationM Gyenes, M Farrant, D H Farb
Human Pathology|June 1, 1995
Pathobiological determinants of cocaine-associated cardiovascular syndromesF D Kolodgie, A Farb, R Virmani
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|October 24, 2001
Sudden cardiac deathR Virmani, A P Burke, A Farb
Human Pathology|July 1, 1993
Ischemia from myocardial coronary bridging: fact or fancy?R Virmani, A Farb, A P Burke
American Heart Journal|January 1, 1994
Coronary angioplasty from the perspective of atherosclerotic plaque: morphologic predictors of immediate success and restenosisR Virmani, A Farb, A P Burke
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 1, 1991
The pathology of primary pulmonary hypertensionA P Burke, A Farb, R Virmani
Journal of the American College of Cardiology|July 1, 1991
Limitation of no reflow injury by blood-free reperfusion with oxygenated perfluorochemical (Fluosol-DA 20%)F D Kolodgie, R Virmani, A Farb
The American Heart Hospital Journal|December 18, 2004
Drug-eluting stents: are they really safe?Renu Virmani, Frank D Kolodgie, Andrew Farb
Pageof 56